ÂÜÀòÂÒÂ×

Dr. Linus S. Lin is the Managing Director of Lilly Chorus, a full-service, autonomous R&D unit within Lilly that specializes in lean to clinical Proof of Concept (POC). Previously at Lilly, he held the positions of Site Head & General Manager, Lilly China Research and Development Center (LCRDC), a diabetes focused R&D center based in Shanghai, and Head, Lilly China Innovation Partnerships (LCIP), an externally focused organization to engage biotech and academic collaborators in China.

Prior to Lilly, Dr. Lin led the Chemistry Service Unit at WuXi AppTec, the top discovery CRO brand in the industry. He started his industry career as a medicinal chemist at Merck Research Laboratories. Over a 15-year span at Merck, he led multiple drug discovery teams delivering 9 preclinical candidates, including 4 completing PhI studies and one completing PhIII studies.

Dr. Lin received his BS in Chemistry from Peking University, obtained his PhD in Organic Chemistry at the University of Wisconsin-Madison, and completed his NIH postdoctoral Fellowship with Nobel laureate Prof. E. J. Corey at Harvard University. His scientific contributions included 120+ peer-reviewed manuscripts and published patents.